Search result for 'general council'

Amit Shah highlights NCDC's Rs 92,500 crore disbursement to cooperative societies in FY25, a 4x increase since 2020-21.

Rupam Roy and Arun Kumar Bishoyi re-elected as general secretary and president of All-India State Bank Officers' Federation (AISBOF) for 2025-2028.

India has urged the WTO to implement stricter regulations on subsidies provided by countries engaged in high seas fishing, highlighting the disparity between its modest support and the substantial...

India proposes a per capita subsidy criteria for fisheries at the WTO, arguing for a fairer approach to overfishing and capacity concerns. This comes amidst discussions on disciplining subsidies...

The World Trade Organization (WTO) has reappointed Ngozi Okonjo-Iweala as its Director-General for a second four-year term, starting September 1, 2024.

Small-scale fisher groups from India, Indonesia, and Bangladesh demand WTO keep fisheries subsidy negotiations out of their purview, citing unfair and unbalanced talks.

All India Bank Officers'' Confederation (AIBOC) re-elected Rupam Roy as general secretary at its 13th Triennial General Council Meeting in Guwahati. Balachandran P M was also re-elected president.

India, supported by South Africa, blocked a China-led attempt to include an investment facilitation pact in the WTO ministerial conference agenda. The proposal, which aimed to be binding on...

Experts warn of systemic concerns with China-led investment facilitation proposal at WTO, potentially impacting developing nations. India and South Africa oppose the agreement.

India reiterates its stance that labour and environment are non-trade issues and should not be discussed at the WTO, highlighting the potential for protectionist measures under the guise of...

India has strongly objected to investment facilitation talks at the WTO, arguing it falls outside the organization's mandate and should be addressed bilaterally.

India, South Africa, Indonesia & Brazil urge WTO to extend patent waiver to COVID-19 diagnostics & therapeutics, citing ongoing pandemic and risk of new variants.